The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Marchenkova L.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Makarova E.V.

Moscow State University of Medicine and Dentistry named after AI Evdokimov, Moscow, Russia, 127473

Benefits of combined calcium and vitamin D in the prevention and treatment of osteoporosis: Renaissance of the paradigm

Authors:

Marchenkova L.A., Makarova E.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2017;20(4): 57‑62

Read: 56240 times


To cite this article:

Marchenkova LA, Makarova EV. Benefits of combined calcium and vitamin D in the prevention and treatment of osteoporosis: Renaissance of the paradigm. Russian Journal of Preventive Medicine. 2017;20(4):57‑62. (In Russ.)
https://doi.org/10.17116/profmed201720457-62

Recommended articles:
The condition of bone tissue in patients with non-alcoholic fatty liver disease. Russian Journal of Preventive Medi­cine. 2025;(5):82-89
Liver and bone in tandem: osteopenia as an inevitable companion to non-alcoholic fatty liver disease. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):40-50
Economic issues of medi­cal care for hype­rparathyroidism. Part 1. Primary hype­rparathyroidism. Medi­cal Technologies. Asse­ssment and Choice. 2025;(1):51-61
Vertebroplasty for pathological vertebral fracture with osteoporosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):67-76

References:

  1. Dreval AV, Marchenkova LA, Kruykova IV, et al. Efficiency of combined therapy of calsium with high and medium doses of vitamin D3 for the postmenopausal osteoporosis prophylaxis. Osteoporosis ans osteopathies. 2007;1:20-24. (In Russ.).
  2. Lesnyak YuF., Lesnyak OM. Analysis for cost-effectiveness minimisation of osteoporosis prophylaxis with calcium and vitamin D. Russian family doctor. 2004;1:22-27. (In Russ.).
  3. Matkovic V, Heaney RP. Calcium balance during human growth: evidence for threshold behavior. Am J Clin Nutr. 1992;55:992-996.
  4. Recker RR, Davies KM, Hinders SM, Heaney RP, Stegman MR, Kimmel DB. Bone Gain in Young Adult Women. JAMA. 1992 Nov 4;268(17):2403-2408.
  5. Marchenkova LA, Dreval AV, Dobritsina MA. Structure of clinical risc-factors of osteoporosis and level of calcium intake in the female population of Moscow region. Lechaschii vrach. 2014;5:89-95. (In Russ.).
  6. Nikitinskaya OA, Toroptsova NV. Social programm «Osteoskrining, Russia» at work. Farmateka. 2012;6:100:103. (In Russ.).
  7. Lesnyak OM, Benevolenskaya LI. Osteoporosis. Ed. 2-nd edition. M.: GEOTAR-Media. 2012. (In Russ.).
  8. Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab. 2011 Aug;25(4):585-591. https://doi.org/10.1016/j.beem.2011.05.002
  9. Kanis JA. Requirements for calcium and its use in the management of osteoporosis. In: Osteoporosis. Eds. Stevenson J, Lindsay R. Chapman @ Hall Medical. London. 1998;215-242.
  10. Rizzoli R, Boonen S, Brandi ML, Burlet N, Delmas P, Reginster JY. The role of calcium and vitamin D in the management of osteororosis. Bone. 2008;42:246-249. https://doi.org/10.1016/j.bone.2007.10.005
  11. Rozhinskaya LYa, Dzeranova LK, et al. The use of calcium and vitamin D in osteoporosis prophylaxis in postmenopausal women. Osteoporosis and osteopathies. 2001l1:29-33. (In Russ.).
  12. Lips P. Vitamin D deficiency and osteoporosis: the role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of ostoporosis — related fractures. European J of Clin Investigarion. 1996;26:436-442.
  13. Lesnyak OM, Nikitinskaya OA, Toroptsova NV. Prophylaxis, diagnosis and treament of vitamin D and calcium defficiency in adult population with osteoporosis. Scientific and practical rheumatology. 2015;53:4. (In Russ.).
  14. Торопцова Н.В., Беневоленская Л.И. Уровень витамина D в сыворотке крови у женщин в постменопаузе. Сборник тезисов 2-го Российского конгресса по остеопорозу. Ярославль, 2005;97-98. [Toroptsova NV, Benevolenskaya LI. Vitamin D level in the blood serum in post-menopausal women. Proceedings of 2nd Russian Congress on Osteoporosis. Yaroslavl. 2005;97-98. (In Russ.).
  15. Bakhtiyarova S, Lesnyak O, Kuznesova N, Blankenstein MA, Lips P. Vitanin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia. Osteoporos Int. 2006;17:441-446. https://doi.org/10.1007/s00198-005-0006-9
  16. Reid IR, et al. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. JAMA. 1995;98(4):331-335.
  17. Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, Burckhardt P, Li R, Spiegelman D, Specker B, Orav JE, Wong JB, Staehelin HB, O’Reilly E, Kiel DP, Willett WC. Calcium intake and hip fracture risk in men and women: a metaanalysis of rospective cohort studies and randomized controlled trials. Am J Clin Nutr. 2007 Dec;86(6):1780-1790.
  18. Cauley JA, Danielson ME, Greendale GA, Finkelstein JE, Yue-Fang Chag, Lo JC, Crandall CJ, Neer RM, Ruppert K, Meyn L, Prairie BA, Sowers MFR. Bone resorptin and fracture across the menopusal transition: the Study of Women’s Health Actoss the Nation Medopause. 2012 Nov;19(11):1200-1207. https://doi.org/10.1097/gme.0b013e31825ae17e
  19. Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P. Need for additional calcium to reduce the risk of hip fracture ith vitanin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clinical Endocrinogy and Metabol. 2007;92(4):1415-1423. https://doi.org/10.1210/jc.2006-1404
  20. Papaioannou A, Kennedy CC, Giangregorio L, Ioannidis G, Pritchard J, Hanley DA, Farrauto L, DeBeer J, Adachi JD. A randomized controlled trial of vitamin D dising strategies after acute hip fracture: no advantage of loading doses over daily spplentation. BMC Musculoskelet Disord, 2011l12:135. Published inline 2011 Jun 20. https://doi.org/101186/1471-2474-12-135
  21. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ. 1994;308:1081-1082.
  22. Kanis JA. Requirements for calcium and its use in the management of osteoporosis. In: Osteoporosis. Eds. Stevenson J, Liondsay R. Chapmen and Hall Medical. London. 1998;215-242.
  23. Galagher JC. Vitamin D treatment in osteoporosis and osteomalacia. In: Osteoporosis. Eds, Stevenson J, Lindsay R. Chapman and Hall Medical. London. 1998;243-262.
  24. Bishoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staegelin HB, Orav EJ, Thoma A, Kiel DP, Henschkowski J. Prevention of nonvertebral fractures with oral vitamin D and dose dependency. A metaanalysis of randomized controlled trials. Arch Intern Med. 2009;169:551-561. https://doi.org/10.1001/archinternmed.2008.600
  25. Tang BM, Eslick GD, Nowson C, Smith C, Bensossan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a metaanalysis. Lancet. 2007;370:657-666.
  26. Dawson-Hughes B. Vitanin D and calcium reconnebded intake for bone health. Osteoporosis Int. 1998;8(suppl):S30-S34.
  27. Salovaara K, Tuppurainen M, Karkkainen M, Rikkonen T, Sandini L, Sirola J, Honkanen R, Alhava E, Kroger H. Eddct of vitamin Dand calcium on fracture risk in 65 to 71-year-old women: a population based 3 year randomized, controlled trial — The OSTPRE-FRS. Journal of Bone and Mineral Researh. 2010;1487-1495. https://doi.org/10.1056/NEJMoa055218
  28. Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int. 2002 13March; (3):187-194. https://doi.org/10.1007/s001980200012
  29. Venning G. Recent developments in vitamin D deficiency and muscle weakness among elderly people. BMJ. 2005 March;330(7490):524-526. https://doi.org/10.1136/bmj.330.7490.524
  30. Bischoff-Ferrari HA, Borchers M, Gudat F, Dürmüller U, Stähelin HB, Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res. 2004 19February;(2):265-269. https://doi.org/10.1359/jbmr.2004.19.2.265
  31. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, Charles P, Eriksen EF. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int. 2000 June;66(6):419-424.
  32. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res. 2000 June;15(6):1113-1118. https://doi.org/10.1359/jbmr.2000.15.6.1113
  33. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB. Effect of vitamin D on falls: a metaanalysis. JAMA. 2004;291:1999-2006. https://doi.org/10.1001/jama.291.16.1999
  34. Kärkkäinen MK, Tuppurainen M, Salovaara K, Sandini L, Rikkonen T, Sirola J, Honkanen R, Arokoski J, Alhava E, Kröger H. Does daily vitamin D 800IU and calcium 1000mg supplementation decrease the risk of falling in ambulatory women aged 65—71 years? A 3-year randomized population-based trial (OSTPRE-FPS). Maturitas. 2010. https://doi.org/10.1016/j.maturitas.2009.12.018
  35. Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster J-Y, Borgstrom F, Rizzoli R. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008;19:399-428. https://doi.org/10.1007/s00198-008-0560-z
  36. Scottish Intercollegiate Guidelines Network (SIGN) # 71: Management of osteoporosis: a national clinical guideline, June 2003. www.sign.ac.uk Scottish Intercollegiate Guidelines Network (SIGN) # 71: Management of osteoporosis: a national clinical guideline, June 2003. www.sign.ac.uk
  37. Institute for Clinical Systems Improvement (ICSI) Health Care Guideline: Diagnosis and Treatment of Osteoporosis, 3rd edition, July 2004. www.icsi.org Institute for Clinical Systems Improvement (ICSI) Health Care Guideline: Diagnosis and Treatment of Osteoporosis, 3rd edition, July 2004. www.icsi.org
  38. Clinical trials.gov:NCT02457247. https://doi.org/10.1080/03007995.2016.1202817
  39. Ettinger В, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med. 1987;106:40-45. https://doi.org/10.7326/0003-4819-106-1-40
  40. Elders PJ, Netelenbos JC, Lips P, van Ginkel FC, Khoe E, Leeuwenkamp OR, Hackeng WH, van der Stelt PF. Calcium supplementation reduces vertebral bone loss in perimenopausal women a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab. 1991; 73:533-540. https://doi.org/10.1210/jcem-73-3-533
  41. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med. 1990;323:878-883. https://doi.org/10.1056/NEJM199009273231305
  42. Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Metaanalysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev. 2002 Aug;23(4):552-559. https://doi.org/10.1210/er.2001-7002
  43. DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ. 2010 Jan 12;340:b5463. https://doi.org/10.1136/bmj.b5463
  44. Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, Orav EJ, Stähelin HB, Willett WC, Can U, Egli A, Mueller NJ, Looser S, Bretscher B, Minder E, Vergopoulos A, Theiler R. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med. 2010 May 10;170(9):813-820. https://doi.org/10.1001/archinternmed.2010.67
  45. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, Stähelin HB, Theiler R, Dawson-Hughes B. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012 Jul 5;367(1): 40-49. https://doi.org/10.1056/NEJMoa1109617
  46. Lewis JR, Radavelli-Bagatini S, Rejnmark L, Chen JS, Simpson JM, Lappe JM, Mosekilde L, Prentice RL, Prince RL.. The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials. J Bone Miner Res. 2015 Jan;30(1):165-175. https://doi.org/10.1002/jbmr.2311
  47. Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR. Relation of calcium, Vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol. 1999;149:151-161.
  48. Hiroyasu Iso, Meir J. Stampfer, JoAnn E. Manson, Kathryn Rexrode, Charles H. Hennekens, Graham A. Colditz, Speizer FE, Willett WC. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke. 1999;30:1772-1779. https://doi.org/10.1161/01.STR.30.9.1772
  49. Griffith LE, Guyatt GH, Cook RJ, Bucher HC, Cook DJ. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens. 1999;12:84-92.
  50. Denke MA, Fox MM, Schulte MC. Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr. 1993;123:1047-1053.
  51. Reid IR, Mason B, Horne A, Ames R, Clearwater J, Bava U, Orr-Walker B, Wu F, Evans MC, Gamble GD. Effects of calcium supplementation on serum lipids concentrations in normal older women: a randomized controlled trial. Am J Med. 2002;112:343-347.
  52. Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, Lichtenstein A, Patel K, Raman G, Tatsioni A, Terasawa T, Trikalinos TA. Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep). 2009;1-420.
  53. Wallace RB, Wactawski-Wende J, O’Sullivan MJ, Larson JC, Cochrane B, Gass M and Masaki K. Urinary tract stone occurrence in the Women’s Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. American Journal of Clinical Nutrition. 2011;94:270-277. https://doi.org/10.3945/ajcn.110.003350
  54. Curhan GC, Willet WC, Knight FL. Dietary factors ad the risk of incident kidney stones in younger women: Nurses’ Health Study II. Arch Intern Med. 2004;885-891. https://doi.org/10.1097/01.ASN.0000146012.44570.20
  55. Scientific Opinion on the Tolerable Upper Intake Level of calcium. EFSA Panel on Dietetic Products, Nutrition and Allergies. EFSA Journal. 2012;10(7):2814-2857.
  56. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D into perspective. Br J Nutr. 2005;94(4):483-492.
  57. Autier P, Gandini S. Vitamin D supplementation and total mortality : a meta-analysis of randomized controlled trials. Intern Med. 2007;167:1730-1737. https://doi.org/10.1001/archinte.167.16.1730
  58. Renmark L, Avenell A, Masud T. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D. J Clin Endocrinol Metab. 2012. https://doi.org/10.1210/jc.2011-3328

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.